Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations

This study is currently recruiting participants.

Study NCT00943943 Information provided by M.D. Anderson Cancer Center

First Received: July 20, 2009 Last Updated: February 2, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	October 2014 (Final data collection date for primary outcome measure)